iifl-logo-icon 1

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

sidebar image

Lupin receives approval from USFDA for Sildenafil for oral suspension

28 Mar 2022 , 11:19 AM

Global pharma major Lupin Limited has received approval from the United States Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA), Sildenafil for Oral Suspension, 10 mg/mL to market a generic equivalent of Revatio® for Oral Suspension, 10 mg/mL, of Viatris Specialty LLC.

The product will be manufactured at Lupin’s facility in Goa, India.

Sildenafil for Oral Suspension, 10 mg/mL (RLD Revatio®) had estimated annual sales of USD 66 million in the U.S., as per IQVIA MAT December 2021.

The stock is currently trading at Rs755.15 down by Rs1.2 or 0.16% from its previous closing of Rs756.35 on the BSE. The scrip opened at Rs756.35 and has touched a high and low of Rs765.60 and Rs754.85 respectively. 

Related Tags

  • Lupin
  • Lupin share price
  • Lupin stock news
  • Lupin USFDA
  • nifty
  • oral suspension
  • sensex
sidebar mobile

BLOGS AND PERSONAL FINANCE

Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.